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Abstract 
The Wilms tumor suppressor gene (Wt1) encodes a transcription factor involved in the 
development of a number of organs, but the role played by Wt1 in pancreatic 
development is unknown. The pancreas contains a population of pancreatic stellate cells 
(PSC) very important for pancreatic physiology. We described elsewhere that hepatic 
stellate cells originate from the WT1-expressing liver mesothelium. Thus, we checked if 
the developmental origin of PSCs was similar. WT1 protein is expressed in the 
pancreatic mesothelium. Between E10.5 and E15.5, this mesothelium gives rise to 
mesenchymal cells that contribute to a major part of the PSC and other cell types 
including endothelial cells. Most WT1systemic mutants show abnormal localization of 
the dorsal pancreas within the mesentery and intestinal malrotation by E14.0. Embryos 
with conditional deletion of WT1between E9.5 and E12.5 showed normal dorsal 
pancreatic bud and intestine, but the number of acini in the ventral bud was reduced 
about 30% by E16.5. Proliferation of acinar cells was reduced in WT1 systemic 
mutants, but pancreatic differentiation was not impaired. Thus, mesothelial-derived cells 
constitute an important subpopulation of pancreatic mesodermal cells. WT1 expression 
is not essential for pancreas development, although it influences intestinal rotation and 
correct localization of the dorsal pancreas within the mesogastrium.   
Keywords: Mesothelium, epithelial-mesenchymal transition, pancreatic stellate cells, 
pancreatic stroma, intestinal rotation. 
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Introduction 
The Wilms tumor suppressor gene (Wt1) encodes a C2H2-type zinc-finger transcription 
factor that can appears in mammals under different isoforms, participating in 
transcriptional regulation, RNA metabolism and protein-protein interactions (1-3). Wt1 
has been involved in the development of a number of organs, including kidneys and 
gonads (4), spleen (5), adrenals (6), liver (7,8), heart (9-11), lungs (12) and diaphragm 
(13). However, there are no reports in the literature about the role played by Wt1 in 
pancreatic development, despite the parallelisms between liver and pancreas 
organogenesis.  
      In mouse, pancreas develops from dorsal and ventral primordia derived from the 
endoderm. The dorsal primordium emerges through evagination of the endodermal 
epithelium starting by E9.5. The ventral pancreatic bud appears later, by the stage 
E10.5. Splanchnic mesodermal cells induce growth and branching of these buds. The 
endodermal cells give rise to the main pancreatic cell types, the exocrine acinar cells, 
ductal cells and endocrine cells from the islets of Langerhans (14). Mesodermal cells 
contribute to the vascular and connective tissue of the pancreas, and also to a pancreas-
specific cell type, the pancreatic stellate cells (PSCs).  
In normal adult pancreas, the pancreatic stellate cells (PSCs) are quiescent, star-
shaped cells with a periacinar distribution. They contain vitamin A-rich lipid droplets in 
the cytoplasm and exhibit positive immunostaining for desmin and glial fibrillary acidic 
protein (GFAP) (15). In normal pancreas, PSCs are involved in keeping the epithelial 
integrity of the pancreatic acini via maintenance of the basement membrane (16,17). 
Furthermore, when activated by profibrogenic stimuli such as inflammatory cytokines 
or oxidant stress, PSCs proliferate and transform into myofibroblast-like cells, 
becoming the major source of extracellular matrix. PSC have also recently become a 
focus of interest since they play a key role in pancreatic cancer, a malignancy with a 
high prevalence and poor prognosis (18-20). Despite this capital importance in normal 
and pathological conditions, the embryonic origin of PSCs remains unknown. 
PSCs are similar to the hepatic stellate cells located in the perisinusoidal space 
of the liver. These cells share many features with PSCs and they are also involved in the 
fibrotic process. It has been described that the liver mesothelium contributes to the 
hepatic stellate cells and vascular endothelium during development (7,8). The local 
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emergence of mesenchymal cells through a localized epithelial-mesenchymal transition 
(EMT) of the coelomic epithelium or mesothelium lining developing organs has been 
extensively studied in some cases, such as the heart, where the epicardium gives rise to 
epicardial-derived cells that contribute to the cardiac vascular and connective tissues 
(21). In other organs, such as the lungs, liver and gut, the developmental fate of the 
mesothelial-derived mesenchyme and their importance for visceral morphogenesis has 
been also demonstrated (For a review, see ref. 22). Thus, we aimed to check if 
pancreatic mesothelium also supplies mesenchymal cells to the developing pancreas and 
if these mesenchymal cells account for the origin of PSCs.  
Our results confirmed that WT1 protein is only expressed in the mesothelium of 
the developing pancreas, allowing for tracing of the mesothelial-derived cells with the 
Cre/LoxP system. During the early stages of pancreas morphogenesis, this mesothelium 
shows the typical features of EMT. Mesothelial-derived cells, identified by YFP 
expression in our model, differentiate into a major part of the PSCs and contribute to 
other cell types, including a part of the vascular endothelium. Conditional deletion of 
WT1 by the time in which the EMT process is generating the PSC, causes a delay in the 
growth of the ventral pancreatic bud, but the development of the dorsal bud and the PSC 
are normal. Systemic WT1 mutants die during the early stages of pancreatic 
development, but they show defects in the mesogastrium, anomalous localization of the 
dorsal pancreatic bud in the mesentery, intestinal malrotation and reduced proliferation 
of acinar cells. Thus, mesothelial-derived cells originated by an EMT constitute a 
significant subpopulation of mesodermal cells during pancreas development and 
modulate its growth, although WT1 seems to be basically dispensable for pancreatic 
differentiation.  
Materials and methods 
The animals used in our research program were handled in compliance with the 
institutional and European Union guidelines for animal care and welfare. The 
procedures used in this study were approved by the Committee on the Ethics of Animal 
Experiments of the University of Malaga (procedure code 2015-0028).  
The Tg(Wt1-cre)#Jbeb (Wt1cre) mouse line has been used in previous studies to 
trace or delete specific genes in WT1-expressing cells (11,12,23-26). For lineage tracing 
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studies, homozygote Wt1cre+/+ were crossed with Rosa26EYFP (B6.129X1-
Gt(ROSA)26Sortm1(EYFP)Cos/J) mice to generate permanent reporter expression in 
Wt1-expressing cells.  
The Wt1tm2(cre/ERT2)Wtp/J allows for inducible Cre-recombinase expression 
in WT1-expressing cells after tamoxifen treatment (27). We have used this line crossed 
with Rosa26EYFP for inducible reporter expression in the WT1 lineage and also to delete 
expression of Wt1 in this lineage when the driver was crossed with a Wt1LoxP mice (10). 
For inducible reporter expression mice were intraperitoneally injected at different stages 
with tamoxifen (Sigma, T5648) dissolved in corn oil (10 mg/mL) at a dose of 0,1 mg/g 
body weight together with 0,05 mg/g body weight of progesterone to reduce abortion 
risk. In one experiment, a single dose was injected at the stage E9.5, and the embryos 
were fixed at E14.5. In a second experiment, three doses of tamoxifen were injected at 
E9.5, E10.5 and E11.5, and the embryos were fixed at E15.5 and E16.5. In the third 
experiment, tamoxifen was injected at E9.5, E10.5, E11.5 and E12.5 and the embryos 
were fixed at E16.5. We always used as controls littermates either Cre- or lacking of 
floxed Wt1 alleles. No differences were observed between both types of controls. The 
Wt1GFP knockin line (28) in which the exon 1 of one Wt1 allele has been replaced by 
the GFP sequence, was also used as an independent reporter for active Wt1 transcription 
and also as a model of WT1 loss of function (Wt1GFP/GFP).  
Embryos were staged from the time point of vaginal plug observation, which 
was designated as the stage E0.5. Whole embryos and the viscera of neonates were 
excised, washed in PBS and fixed in 4 % fresh paraformaldehyde solution in PBS for 2-
8 h. Then, the embryos were paraffin-embedded or washed in PBS, cryoprotected in 
sucrose solutions, embedded in OCT and frozen in liquid N2-cooled isopentane. Ten 
m cryosections were stored at -20ºC until use. 
 Immunofluorescence was performed using routine protocols. 
Deparaffinized sections or cryosections were rehydrated in Tris-PBS (TPBS) and 
blocked for non-specific binding with SBT (16% sheep serum, 1% bovine albumin, 
0.1% Triton X-100 in TPBS). When biotinylated secondary antibodies were used, 
endogenous biotin was blocked with the Avidin-Biotin blocking kit from Vector. Single 
immunofluorescence was performed incubating the sections with the primary antibody 
overnight at 4ºC, washing in TPBS and incubating with the corresponding 
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fluorochrome-conjugated secondary antibody. Double immunofluorescence was 
performed by mixing both primary antibodies (rabbit polyclonal and mouse or rat 
monoclonal), and incubating overnight at 4ºC. We then used a Cy5-conjugated and a 
biotin-conjugated secondary antibody, followed by 45 min incubation with TRITC-
conjugated streptavidin. Nuclei were counterstained with DAPI (Sigma D-4592). 
Details of the antibodies used in this study are provided in Table 1. 
 For flow cytometry analysis, pancreas from Wt1cre/Rosa26REYFP embryos 
were excised, dissociated for 15 min at 37ºC in 0.1% collagenase solution in PBS and 
homogenized by repeated pipetting. Cell suspension was washed in PBS plus 2% fetal 
bovine serum and 10 mM HEPES. Then, cells were incubated on ice at the dark with 
Cy5-conjugated rat Anti-mouse CD31 (Pecam-1). After washing, the cells were 
analyzed in a MoFlo cell sorter.  
For time-lapse video recording, E12.5 Wt1Cre/ROSA26REYFP mouse embryos 
were dissected in sterile PBS. Caudal stomach and proximal duodenum were isolated 
and cultured as previously described (29). Basically, organ explants were transferred to 
coverglass bottomed dishes coated with 20 μl Matrigel™ and placed in a 37°C 
incubator for 20 min to solidify the Matrigel™. The rudiments were then covered with 
medium (DME H-16/F-12 1:1 supplemented with 10% FBS, antibiotics and insulin-
transferrin-selenium). After 24 h of culture, images were captured in a Leica SP5 
confocal microscope every 5 min for 6 h. During the capture, the culture chamber was 
maintained at 37°C in a 5% CO2 humidified atmosphere.  
Analysis of the differences between dorsal and ventral pancreatic buds was 
performed on images taken from paraffin sections of four E16.5 Wt1creERT2;Wt1flox 
mutants and four control littermates, using between 4-6 images for each embryo. In 
total, 39 sections were analysed. The contour of the dorsal and ventral pancreatic buds 
were drawn, and the acini were manually recorded for each section. Number of acini 
and surface of the pancreatic contours were calculated using ImageJ software. The mean 
values obtained for each embryo were compared using Student’s t-test, since the KS test 
found the data consistent with a normal distribution. 
For the proliferation study, the acinar surface was measured as described above 
and the number of PH3+ acinar cells counted (N=6 systemic mutants and 8 controls, 15 
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and 20 sections analysed, respectively). Since one of the data sets was not consistent 
with a normal distribution, U-Mann Whitney test was used to compare the values 
obtained. 
Results 
Pancreatic mesothelium expresses WT1 and gives rise to mesenchymal cells during 
development 
WT1 expression in the pancreas is basically restricted to the mesothelium in all the 
stages studied. A faint WT1 immunoreactivity can be seen in a few submesothelial cells 
from early (E12.5-E13.5) embryos suggesting downregulation of WT1 expression 
during the EMT of the mesothelium, as described in other organs (12). However, no 
WT1 expression was detected in the mesoderm surrounding the pancreatic epithelium 
(Figure 1A-C). Thus, the driver Wt1Cre is a reliable marker for the mesothelial-derived 
cells during pancreatic development. 
 Morphological features of EMT were observed in the pancreatic mesothelium at 
the earliest stages studied (E12.5 and E13.5), including discontinuous laminin 
immunoreactivity, reduced E-cadherin expression, loose lateral adhesion between 
mesothelial cells and basal cytoplasmic processes (Figure 1D-F). These signs coincided 
with a punctate pattern of cytokeratin immunostaining in the submesothelial cells, 
suggesting collapse of the epithelial-type cytoskeleton (Figure 1E). Continuous laminin 
immunoreactivity appears in the basal lamina of the pancreatic mesothelium by E15.5, 
and mesothelial cells express E-cadherin in later stages (Figure 1G,H), suggesting a 
downregulation of the EMT process. RALDH2, the main enzyme for retinoic acid 
synthesis in the mesoderm, was immunolocalized in the pancreatic mesothelium at all 
the stages studied (Figure 1H).  
 Time lapse video recording of pancreatic explants obtained from E12.5 
Wt1cre;R26REYPF embryos showed areas of EMT where YFP+ cells were migrating from 
the mesothelium towards the growing acini (Supplemental Figure 1A,C and 
Supplemental video 2). However other areas showed a thick, quiescent mesothelium 
lacking of signs of EMT (Supplemental Figure 1B and Supplemental video 1). 
Interestingly, YFP+ cells were observed migrating and intercalating between the 
branching acini (Supplemental Figure 1D and Supplemental video 3). 
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 Cell counts on confocal images taken from two E12.5 Wt1cre;R26REYPF embryos 
(four images each) show that 58.6±2.1% of the mesenchymal cells of the pancreas are 
YFP+, and thus they belong to the WT1-expressing cell lineage. Induction of the Cre-
recombinase expression by E9.5 in the Wt1creERT2;R26REYFP model provoked the 
staining of very few cells in the pancreatic stroma of E14.5 embryos (Figure 1I), 
contrasting with the massive staining of Sertoli cells in the testis. However, induction 
between E9.5 and E11.5 greatly increased the number of stromal YFP+ cells by E15.5 
(Figure 1J). This suggests that most cells derived from the WT1-expressing cell lineage 
(i.e. putative mesothelial-derived cells) originate after E10.5, when the pancreatic buds 
start growing. 
A major part of pancreatic stellate cells derives from the WT1-expressing cell lineage 
 YFP colocalized with desmin, a marker of PSC, in many periacinar mesenchymal 
cells from the Wt1cre;R26REYPF embryos from E14.5 on (Figure 2A,B). Some of these 
cells project thin cytoplasmic projections between the acinar cells, a characteristic 
feature of PSC (Figure 2A). WT1-expressing lineage cells also contribute to the 
subpopulation of desmin-positive, islet PSC (Figure 2B). Colocalization of YFP with 
GFAP, another marker of pancreatic stellate cells, confirmed the mesothelial origin of 
islet PSC in older embryos, about E18.5 (Figure 2C). No differences were found 
between dorsal and ventral pancreatic buds in the contribution of WT1-expressing 
lineage cells (Supplemental Figure 2) 
 The contribution from mesothelial-derived cells to the vascularization of the 
pancreas was also studied. A number of perivascular cells expressing NG2 (a pericyte 
marker) are YFP+ (Figure 2D), and YFP also colocalized with the endothelial marker 
CD31/Pecam-1 (Figure 2E,F).  
 In order to confirm and to quantify the contribution of YFP+ cells to the pancreatic 
endothelium we performed analytic flow cytometry of disaggregated pancreas obtained 
from four E14.5 embryos. The results (Figure 3) show that about a third of all the 
pancreatic cells by this stage belongs to the WT1-expressing cell lineage (34,7%±1,9, 
mean±SEM, n=4). 3,1%±0,2 of the total cells analysed are endothelial and from them, 
9,2%±1,1 are YFP+. 
Wt1 deletion in mesothelium causes a delay in ventral pancreas growth, defective 
mesogastrium, abnormal dorsal pancreas location and intestinal malrotation 
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In order to check if WT1 expression is required for pancreatic development we studied 
both, embryos with systemic deletion of WT1 (Wt1GFP/GFP) and Wt1creERT2;Wt1flox 
embryos induced with tamoxifen at different times. Most systemic WT1-null embryos 
die before the stage E13.5 and their pancreas are too small in order to detect anomalies 
in their development. The eight Wt1GFP/GFP embryos obtained by the stages E13.5 and 
14.5 showed pancreas of similar size when compared with the control heterozygote 
littermates (Wt1GFP/+) (Figure 4A-H). However, these embryos with loss of WT1 
function showed defective development of the mesogastrium, leading to an abnormal 
location of the dorsal pancreas, that was embedded in the mesenteric wall. In one case, 
pancreatic tissue was observed inside the liver, due to this anomalous position (Figure 
4G). Surprisingly, in six out the eight mutant embryos analysed the duodenum was 
located close to the larger curvature of the stomach, at the left side, suggesting an 
intestinal malrotation (Figure 4E-H). In some of these cases the hindgut was abnormally 
placed at the right side (Figure 4E,F).  
 Tamoxifen treatment of Wt1creERT2;Wt1flox embryos between E9.5 and E11.5 
(three doses) and fixed at stages E15.5 and E16,5 suppressed WT1 expression in the 
pancreas (Figure 4I,J), but this deletion did not cause differences in pancreatic 
development (not shown). However, WT1 deletion induced between E9.5 and E12.5 
(four doses) and analysed at E16.5 showed a significant delay in the development of the 
ventral pancreatic bud, characterized by a smaller number and smaller density of acini 
as compared with the controls (Figures 4K,L and 5A,B). However, anomalies were not 
found in dorsal pancreatic buds, intestine or mesogastrium in these mutant embryos. 
(Figure 4K,L). 
 We then studied the proliferation of the pancreatic acinar cells in systemic 
Wt1GFP/GFP mutant embryos by immunolocalization of phosphohistone-H3 (Figure 5C). 
The mitotic rate (expressed as number of PH3+ cells by acinar surface) was 
significantly lower than the obtained from control Wt1GFP/+ littermates when we 
considered dorsal and ventral pancreas together (p=0.012, U Mann-Whitney test, Figure 
5C). Dorsal and ventral mutant pancreas considered separately showed a trend to 
reduced proliferation, very close to statistical significance (p=0.06 and p=0.08, 
respectively).  
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 All E16.5 control and mutant embryos with conditional deletion of Wt1 showed 
similar immunoreactive patterns of amylase, insulin, glucagon, Ptf1a, mucin, desmin, E-
cadherin, PDX1, neurogenin and RALDH2 (some examples shown in Suppl. Figure 3). 
This suggests that the developmental delay did not affect the pancreatic differentiation. 
Particularly, the number of desmin+, pancreatic stellate cells was similar in both, 
conditional Wt1 mutant and control embryos. 
Adult mesothelium does not contribute to renewal of the pancreatic stellate cell 
population 
In order to check if the adult mesothelium is still contributing to the stellate cell 
population in adult mice we induced Wt1 reporter expression in a Wt1cre;R26REYPF adult 
mouse (four weeks old) and then we checked the presence of YFP+ stellate cells in the 
pancreas after one month. The pancreatic mesothelium was YFP+, but no positive cells 
were found inside the pancreas, thus suggesting the lack of a postnatal contribution of 
the mesothelium to the pancreatic stellate cells (Suppl. Figure 4). 
Discussion 
We show in this paper that the pancreas, as described for other viscera (for a review, see 
ref. 22), receives a substantial contribution of mesothelial-derived cells originated by a 
process of epithelial-mesenchymal transition. Our findings confirm, using a genetic 
model of lineage tracing, the recently published results obtained by direct labeling of the 
pancreatic mesothelium (30). We have also shown that WT1 is expressed in the 
embryonic mesothelium of the pancreas and it is rapidly downregulated as 
mesenchymal cells arise from it and migrate into the developing organ, intercalating 
between the branching endodermal tissue. Thus, Wt1Cre is a reliable driver for cell 
tracing of the mesothelial-derived cells during pancreatic development. The main part of 
this process of generation of pancreatic stroma occurs between E10.5 and E14.5, as 
suggested by the scarce labelling of mesenchymal cells when reporter activation is 
performed by E9.5 and by the epithelialization of the pancreatic mesothelium and the 
disappearance of EMT signs by E15.5. Mesothelial-derived cells contribute to the 
vascularization of the developing pancreas giving rise to a minor part of the 
endothelium (about 10% by midgestation) and perivascular cells. Furthermore, as it has 
been also described for other developing organs, mesothelial-derived cells contribute to 
an organ-specific cell type, the pancreatic stellate cells, including the subtype known as 
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islet stellate cells (31). This contribution is significant, accounting for more than a half 
of the PSC by midgestation. In adults, we have seen that about 15-30% of the PSC still 
belong to a WT1-expressing lineage (not shown), but a postnatal contribution of the 
mesothelium to the PSC population seems not significant (Suppl. Figure 4). However, 
we cannot conclude that the adult PSC of the WT1-expressing lineage have originated 
from the embryonic mesothelium, since postnatal expression of WT1 occurs during PSC 
activation (ref. 32 and our unpublished observations). Anyhow, the embryonic origin of 
the PSC shows commonalities with the origin of the similar hepatic stellate cells, many 
of them also emerging from the embryonic mesothelium (7,8). 
 Despite this significant contribution of WT1-expressing cells to the pancreatic 
stroma, WT1 seems to be basically dispensable for pancreas development, differently to 
many other viscera, as detailed in the introduction. After conditional WT1 deletion 
between E9.5 and E12.5, pancreatic bud develops normally at least until E16.5, 
although the growth of the ventral pancreatic bud growth is delayed, showing a 30% 
reduction in the number and density of acini. This delay can be explained by the 
decrease in proliferation of endodermal cells that we have observed in systemic WT1 
mutants between E13.5 and E14.5. The reduced proliferation suggests some kind of 
WT1-dependent signaling mechanism acting in the mesothelial-derived cells. In fact, 
the liver size is also hypoplasic in WT1-null mice (7).  
 Pancreatic size was normal in E13.5 and E14.5 WT1 systemic mutants (the oldest 
stage reached by these embryos). However, the mesogastrium showed defective 
development and, as a consequence, the dorsal pancreatic bud was mislocated into the 
dorsal mesentery. Unexpectedly, in six out eight WT1 systemic mutants we observed an 
intestinal malrotation, with the duodenum placed at the left side, along the greater 
curvature of the stomach. This phenotype does not appear in the conditional WT1 
deletion performed between E9.5 and E12.5. Thus, early WT1 expression (before E9.5) 
seems to be required for the development of the mesogastrium and the correct rotation 
of the intestine. A similar phenotype of intestinal malrotation has been described in 
mice with loss of function of both, the homeodomain transcription factors BARX1 and 
PITX2 (33,34). Importantly, BARX1 loss of function leads to decreased expression of 
WT1 (35). Thus, WT1 is involved in L-R patterning of the intestine, probably through 
its role in the development of the mesogastrium and mesenteries. In fact, WT1 function 
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is critical for the organization of other coelomic components, such as the 
pleuropericardial membranes (9) and the diaphragm (13).  
 We could not study further pancreatic development in older systemic WT1 mutant 
embryos due to the mortality caused by defects in other viscera (basically the heart). 
Thus, we cannot know if the difference between dorsal and ventral buds can expand in 
later stages, or if the formation of the endocrine pancreas might be compromised by the 
lack of WT1.  
  In summary, the pancreas becomes a new addition to the list of organs whose 
morphogenesis is regulated by WT1, although in this case the impact of the WT1 loss of 
function is very low as compared with other viscera as the heart, kidney, adrenals, 
gonads or spleen, i.e. the mesodermal organs. The situation is similar to that described 
in other endodermal organ, the liver, where the lack of WT1 only results in a reduced 
size and an abnormal lobing (7). The pancreatic stroma, as described for many other 
viscera, shows also a mixed origin, from the splanchnopleural mesoderm and from 
WT1-expressing mesothelial-derived cells. Finally, we have shown that an organ-
specific cell type, the PSC, can also originate from embryonic mesothelium, as occurs in 
the testicle (Sertoli cells), ovary (granulosa cells) or intestine (Cajal interstitial cells) 
(for a review, see ref. 22).   
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Figure Legends 
Figure 1. Origin of pancreatic stromal cells from the embryonic mesothelium. A-C. 
Wt1Cre;R26REYFP embryo, E12.5 (A), E13.5 (B) and E15.5 (C). Wt1 protein is shown in 
red and the YFP reporter of the Wt1 lineage is shown in green. Actual Wt1 expression 
is restricted to the pancreatic mesothelium in all cases (arrows), although cells of the 
Wt1 lineage are already present in the pancreatic stroma by E12.5, where a faint Wt1 
immunoreactivity can be seen in a few submesothelial cells (arrowheads in A). D. 
Wt1Cre;R26REYFP embryo, E12.5. Laminin immunoreactivity is shown in red. The basal 
lamina is disorganized in areas where YFP+ cells are more abundant (insert) suggesting 
epithelial-mesenchymal transition. E. Wt1Cre;R26REYFP embryo, E12.5. Cytokeratin 
immunoreactivity (in red) shows a characteristic punctiform pattern in mesenchymal 
cells, suggesting collapse of the cytokeratin cytoskeleton, another feature of epithelial-
mesenchymal transition (insert). F. Wt1Cre;R26REYFP embryo, E12.5. E-cadherin 
immunoreactivity (red) is lacking in areas of the mesothelium by this stage (upper 
insert) while other mesothelial cells show E-cadherin immunoreactivity (lower insert). 
Loss of E-cadherin expression in an epithelium is another feature of epithelial-
mesenchymal transition. G. Wt1Cre;R26REYFP embryo, E15.5. Laminin (red) is detected 
by this stage in a continuous basal lamina of the mesothelium (arrows). H. 
Immunolocalization of E-Cadherin (red) and RALDH2 (green) in an E15.5 embryo. 
Epithelialization of the mesothelium at this stage is demonstrated by expression of E-
cadherin between mesothelial cells (arrows). I. Wt1CreERT2;R26REYFP embryo, E14.5. 
Expression of the reporter YFP (green) was induced at E9.5. Only a few cells appear 
labelled in the pancreatic stroma, suggesting a later origin for the mesothelial-derived 
cells. However, positive cells are very abundant in the Sertoli cells of the testis (T). J. 
Wt1CreERT2;R26REYFP embryo, E15.5, with reporter induction between the stages E9.5 
and E11.5. Mesothelial-derived cells, belonging to the Wt1-expressing lineage, are far 
more abundant than in the previous case. I: intestine; LI: liver; P: pancreas; ST: 
stomach. Scale bars=50 m, except A,H (25 m) and I (100  m).  
Figure 2. Developmental fate of the Wt1-expressing cell lineage in Wt1Cre;R26REYFP 
embryos. A-B. Desmin, a marker of pancreatic stellate cells (PSC), colocalizes with 
YFP (arrows) in many cells of the developing pancreas by the stages E15.5 (A) and 
E18.5 (B). The thin prolongations of PSC can be seen between acinar cells (arrowheads 
in A). In the E18.5 embryo YFP+/Desmin+ cells can be seen in a developing islet (IS) 
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(arrowhead in B). These probably are islet stellate cells. Note colocalization around a 
vessel (V). The musculature of the intestine (I) is also desmin immunoreactive. C. Glial-
fibrillary acid protein (GFAP) also colocalizes with YFP in some presumptive islet 
pancreatic stellate cells by the stage E18.5 (arrows). GFAP+ nerve fibers (NF) can be 
seen around a vessel. D. Neuron glia antigen-2 (NG2), a marker of pericytes and other 
perivascular cells colocalizes with YFP in the wall of the developing pancreatic vessels 
and capillaries (arrows) (stage E18.5). E-F. Colocalization of Pecam-1/CD31 with YFP 
in the pancreatic endothelium (arrows) by E16.5 (E) and E18.5 (F). Note the presence of 
YFP+ cells in the media of the developing arteries (arrowheads). Scale bars=50 m. 
Figure 3. Analytical cytometry of developing pancreas at the stage E14.5. 
Representative experiment of the data obtained from four embryos. About 10% of all 
the endothelial cells are YFP+ (i.e., derived from a Wt1-expressing cell lineage). About 
35% of the pancreatic cells, by this stage, are derived from the same lineage. 
Figure 4. Pancreatic phenotype after systemic (Wt1GFP/GFP) and conditional (Wt1 
Wt1creERT2;Wt1flox) embryos. A-H. E13.5-E14-5 embryos with systemic deletion of Wt1 
(B,D-H) and control littermate (A,C). The dorsal mesogastrium (MG) is thickened in 
the mutant shown in B and D and remains largely attached to the mesentery (ME). The 
dorsal pancreatic bud is covered by the mesothelium (M) in the control, but this occurs 
only partially in this mutant, that shows the pancreas partially located in the mesentery 
(ME)(C,D). Note the abnormal development of the mesonephros (MN, arrows in B), 
gonads (G) and adrenals (AD) in the mutant embryo, as well as the hypoplastic liver 
(L). In the mutant embryos shown in panels E-H, the phenotype is more severe, the 
ventral mesogastrium is absent and the dorsal pancreas is embedded in the mesentery. In 
one case, the dorsal pancreas grows into the liver (panel G). In these mutant embryos 
the intestine is abnormally rotated, and the duodenum (D) is located at the left side, 
close to the stomach (ST). In two mutant embryos the hindgut (HG) is also 
malpositioned at the left side (panels G,H) PV: ventral pancreatic bud.. I,J. Wt1 is 
efficiently deleted in the mesothelium of the ventral bud of the pancreas of E15.5 
Wt1creERT2;Wt1flox embryos after tamoxifen treatment between E9.5 and E11.5. K,L. 
Deletion of Wt1 by tamoxifen treatment between E9.5 and E12.5 causes a delay in the 
development of the ventral pancreatic bud, whose acini appear more disperse in this 
E16.5 embryo. No differences can be found in the dorsal pancreatic bud, mesogastrium 
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or duodenum. Note the lack of kidneys (K) and the normal mesogastrium in the mutant 
embryo. Scale bars=500 m, except C,D (100 m) and I,J (50  m) 
 
Figure 5. A,B. Results of image analysis on histological sections from E16.5 
Wt1creERT2;Wt1flox and control embryos, treated with tamoxifen between E9.5 and 
E12.5. A: Average number of acini in the dorsal (D) and ventral (V) pancreatic buds 
from four conditional mutant and four control embryos. Between 4 and 6 sections were 
analyzed from each embryo (39 sections in total). B: Acinar density calculated by 
number of acini/pancreatic surface. Both, number and density of acini in the mutant 
ventral bud were significantly lower as compared with the controls (* = p<0.05; ** = 
p<0.01). No differences were found between the dorsal pancreatic buds. C: Box plots of 
the frequency of PH3+ cells by acinar surface in dorsal and ventral pancreas of E13.5-
E14.5 WT1 systemic mutants. The horizontal bar represents the median, the boxes 
contain the values between the Q1 and Q3 quartiles and the vertical bars represent the 
full range of the values. A significant reduction (p<0.05, U Mann-Whitney test) was 
found when the data from dorsal and ventral pancreas were gathered and compared with 
the controls (N=6 mutants, 8 controls). Proliferation index was also lower in dorsal and 
ventral pancreas separately, but the differences were not significant at the p<0.05 level 
(p=0.06 and 0.08, respectively). 
 
Supplemental Figure 1. Frames obtained from time lapse videos of a Wt1Cre;R26REYPF 
cultured pancreatic explant. A. Clear field image of the explant, marking the areas 
where the frames shown in panels B, C and D were obtained. B. Area of quiescent 
mesothelium, which appears thick and lacks of signs of epithelial-mesenchymal 
transition (EMT). C. Area of active mesothelium, showing signs of EMT. The cells 
marked with coloured dots are migrating towards the acini located at the right of the 
figure. D. Group of developing acini. YFP+ cells can be seen intercalating between the 
branching endodermal tissue (arrows).  
Supplemental Figure 2. Wt1Cre;R26REYPF E16.5 embryo. No differences were found in 
the contribution of YFP+ cells in the dorsal and ventral pancreas. In both cases we can 
see contribution to desmin-expressing and endomucin-expressing cells (arrows).  
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Supplemental Figure 3. Histological sections from E16.5 Wt1creERT2;Wt1flox and 
control embryos, treated with tamoxifen between E9.5 and E12.5. Despite the 
conditional deletion of Wt1, the differentiation of the pancreas appears normal as 
suggested by the expression of mucin, amylase, insulin, desmin or RALDH2. 
Supplemental Figure 4. Induction of Wt1 reporter expression in a Wt1Cre;R26REYPF 
adult mouse (four weeks old). After one month, the pancreatic mesothelium was YFP+, 
but no positive cells were found inside the pancreas, suggesting lack of postnatal 
contribution of mesothelial-derived cells to this organ.  
Supplemental videos. Time-lapse video recording of cultured pancreatic explants from 
E12.5 Wt1cre/ROSA26R-EYFP mouse embryos. The videos were obtained after 24 h 
of culture. The frames shown in supplemental figure 1 were obtained from these videos. 
Video 1: Area of quiescent mesothelium; Video 2: Area of activated mesothelium, 
showing signs of epithelial-mesenchymal transition; Video 3: group of developing acini 
(dark circular areas). YFP+ cells can be seen intercalating between the acini.  
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Table 1. Antibodies used in this study 
Antibody Supplier Clone or Ref. Dilution 
 Monoclonal rat Anti-mouse CD31 
(PECAM) 
Pharmingen Ref. 550274 1/20 
Monoclonal mouse anti alpha smooth 
muscle actin 
Sigma Clone 1A4  Ref. 
A2547 
1/100 
Rabbit polyclonal anti-pan cytokeratin Dako Ref. Z0622 1/100 
Rabbit polyclonal anti-laminin Sigma Ref. L9393 1/200 
Rabbit polyclonal anti-alpha NG2 Abcam Ref. ab 5320 1/50 
Rabbit polyclonal anti-ALDH1A2 Abcam Ref. ab75674 1/200 
Rabbit polyclonal anti-phosphohistone 
H3 
Millipore Ref. 06-570 1/100 
Chicken polyclonal anti-GFP Abcam Ref. ab 13970 1/200 
Mouse monoclonal Anti-E-Cadherin BD Ref 610181 1/200 
Mouse monoclonal anti-Wt1 Millipore MAB4234 1/100 
Chicken polyclonal anti-GFAP Millipore Ref. ab5541 1/200 
Mouse monoclonal anti-desmin Sigma Ref D1033 1/75 
Hamster anti-mucin Thermo Sci. HM-1630 1:300 
Mouse anti-amylase Santa Cruz Sc-46657 1:200 
Mouse anti-insulin Sigma I2018 1:500 
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